LETTER
Enantioselective Synthesis of b-Lactams
1115
(9) Typical Procedure for the Synthesis of b-Lactams 3.
A mixture of carboximide 1 (1.0 mmol), imine 2 (1.2 mmol)
and zinc dust (3 mmol) in THF (5 mL) was refluxed for 10–
20 min, cooled to r.t., poured into H2O (5 mL), and then
extracted with CH2Cl2 (3 × 5 mL). The combined extracts
were washed with brine, dried over anhyd Na2SO4, and
evaporated in vacuo. The residue was chromatographed
through a silica gel column with hexane–EtOAc to give pure
b-lactams 3 and chiral auxiliary 4.
References and Notes
(1) Gilman, H.; Speeter, M. J. Am. Chem. Soc. 1943, 65, 2255.
(2) (a) Singh, G. S. Tetrahedron 2003, 59, 7631.
(b) Enantioselective Synthesis of b-Amino Acids, 2nd ed.;
Juaristi, E.; Soloshonok, V. A., Eds.; Wiley-VCH: Hoboken,
2005.
(3) (a) Magriotis, P. A. Angew. Chem. Int. Ed. 2001, 40, 4377.
(b) Ojima, I.; Delaloge, F. Chem. Soc. Rev. 1997, 26, 377.
(c) Ojima, I. Acc. Chem. Res. 1995, 28, 383. (d) Chemistry
and Biology of b-Lactam Antibiotics, Vol. 1–3; Morin, R. B.;
Gorman, M., Eds.; Academic Press: New York, 1982.
(e) Dürckheimer, W.; Blumbach, J.; Latrell, R.;
Scheunemann, K. H. Angew. Chem., Int. Ed. Engl. 1985, 24,
180. (f) Nagahara, T.; Kametani, T. Heterocycles 1987, 25,
729. (g) The Chemistry of b-Lactams; Page, M. I., Ed.;
Chapman and Hall: London, 1992.
(4) (a) Alcaide, B.; Almendros, P. Curr. Med. Chem. 2004, 11,
1921. (b) Deshmukh, A. R. A. S.; Bhawal, B. M.;
Krishnaswamy, D.; Govande, V. V.; Shinkre, B. A.;
Jayanthi, A. Curr. Med. Chem. 2004, 11, 1889. (c) Alcaide,
B.; Almendros, P. Synlett 2002, 381. (d) Palomo, C.;
Aizpurua, J. M.; Ganboa, I.; Oiarbide, M. Synlett 2001,
1813. (e) Alcaide, B.; Almendros, P. Chem. Soc. Rev. 2001,
30, 226.
(5) (a) Hart, D. J.; Ha, D. C. Chem. Rev. 1989, 89, 1447.
(b) Chen, L.; Zhao, G.; Ding, Y. Tetrahedron Lett. 2003, 44,
2611.
(6) (a) France, S.; Weatherwax, A.; Taggi, A. E.; Lectka, T. Acc.
Chem. Res. 2004, 37, 592. (b) Tomioka, K.; Fujieda, H.;
Hayashi, S.; Hussein, M. A.; Kambara, T.; Nomura, Y.;
Kanai, M.; Koga, K. Chem. Commun. 1999, 715.
(7) Jian, S. Z.; Ma, C.; Wang, Y. G. Synthesis 2005, 725.
(8) Seki, M.; Miyake, T.; Izukawa, T.; Ohmizu, H. Synthesis
1997, 47.
(3S,4R)-4-(4-Chlorophenyl)-3-methyl-1-phenylazetidin-
2-one (3a): 1H NMR (500 MHz, CDCl3): d = 1.51 (d, J = 7.4
Hz, 3 H), 3.16 (dq, J = 2.4, 7.4 Hz, 1 H, H-3), 4.61 (d, J = 2.4
Hz, 1 H, H-4), 7.06 (m, 1 H) 7.26–7.43 (m, 9 H). 13C NMR
(125 MHz, CDCl3): d = 13.35, 55.56, 62.97, 117.21, 123.99,
126.07, 128.69, 129.28, 129.38, 138.08, 138.20, 168.63.
ESI-MS: m/z = 238 [M + H]+.
(3S,4S,E)-3-Ethyl-1-phenyl-4-styrylazetidin-2-one (3j):
1H NMR (500 MHz, CDCl3): d = 1.09 (t, J = 7.4 Hz, 3 H),
1.83 (m, 1 H), 1.94 (m, 1 H), 3.06 (m, 1 H, H-3), 4.33 (dd,
J = 1.9, 8.4 Hz, 1 H, H-4), 6.30 (dd, J = 8.4, 15.9 Hz, 1 H),
6.78 (d, J = 15.9 Hz, 1 H), 7.03–7.50 (m, 10 H). 13C NMR
(125 MHz, CDCl3): d = 11.63, 21.85, 59.21, 60.04, 117.03,
123.93, 126.83, 127.67, 128.53, 128.95, 129.28, 133.84,
136.02, 138.56, 167.61. ESI-MS: m/z = 278 [M + H]+, 300
[M + Na]+, 577 [2 M + Na]+.
(10) Cainelli, G.; Panunzio, M.; Bandini, E.; Martelli, G.; Spunta,
G. Tetrahedron 1996, 52, 1685.
(11) CCDC 273640 contains the supplementary crystallographic
data (excluding structure factors) for compound 3b. These
cam.ac.uk/conts/retrieving.html [or from the Cambridge
Crystallographic Data Centre, 12, Union Road, Cambridge
CB2 1EZ, UK; fax: +44(1223)336033; or
deposit@ccdc.cam.ac.uk].
Synlett 2006, No. 7, 1113–1115 © Thieme Stuttgart · New York